COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
- Resource Type
- Discussion
- Authors
- Adeyeye, Moji; Antignac, Marie; Ashenef, Ayenew; Awab, Ghulam Rahim; Babar, Zaheer-Ud-Din; Bannenberg, Wilbert J; Bond, Katherine C; Bower, Jason; Breman, Joel; Brock, Aleisha; Caillet, Céline; Coyne, Philip; Day, Nicholas; Deats, Michael; Douidy, Kawtar; Doyle, Kim; Dujardin, Catherine; Ejekam, Chioma S; Fernández, Facundo; Freifeld, Clark; Gill, Marie; Guerin, Philippe J; Harigwo, Georgina; Heide, Lutz; Horby, Peter; Kaur, Harparkash; Kayumba, Pierre Claver; Kazuko, Kimura; Kelly, Cassandra; Khuluza, Felix; Kigera, Stephen; Lalani, Mirza; Lamy, Marie; Lieberman, Marya; Lumpkin, Murray; Mackey, Tim; Naughton, Bernard; Newton, Paul N; Nguyen, Philip; Olliaro, Piero; Ozawa, Sachiko; Patel, Anushka; Phanouvong, Souly; Pisani, Elizabeth; Pyzik, Oksana; Rägo, Lembit; Rahman, Mohammad Sofiqur; Ranjit, Eurek; Ravinetto, Raffaella; Richmond, David; Singh-Phulgenda, Sauman; Venema, Jaap; Vogt, Andrea; White, Nicholas; Wirtz, Veronika J; Zaman, Muhammad
- Source
- In The Lancet Global Health June 2020 8(6):e754-e755
- Subject
- Analysis and Interpretation
Comment
- Language
- ISSN
- 2214-109X